| Neoplasm by Morphology investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 395show all (up to 200) |
|---|
| → investigated in trials for | Cyclophosphamidesmall molecule 584 trials (133 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 584 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 573 trials (104 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 573 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 545 trials (127 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 545 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 342 trials (143 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 342 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 301 trials (185 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 301 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 255 trials (61 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 255 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 227 trials (84 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 227 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 227 trials (31 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 227 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 222 trials (36 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 222 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 221 trials (25 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 221 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 206 trials (19 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 206 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 191 trials (78 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 191 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 186 trials (16 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 186 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 182 trials (74 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 182 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daunorubicinsmall molecule 159 trials (32 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 159 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 158 trials (65 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 158 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 156 trials (42 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 156 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 151 trials (53 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 151 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idarubicinsmall molecule 148 trials (26 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 148 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 141 trials (61 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 141 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 140 trials (27 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 140 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 137 trials (56 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 137 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 136 trials (29 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 136 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 129 trials (32 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 129 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 127 trials (26 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 127 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 112 trials (34 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 112 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 99 trials (10 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 99 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 95 trials (18 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 95 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 92 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 92 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 84 trials (50 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 84 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 83 trials (25 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 83 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 79 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 79 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemtuzumab Ozogamicinadc 78 trials (14 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 78 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 74 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 74 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 72 trials (43 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 72 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 71 trials (20 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 71 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 69 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 69 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 67 trials (19 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 67 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 67 trials (34 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 67 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 66 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 66 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 66 trials (30 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 66 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 65 trials (19 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 65 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 64 trials (18 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 64 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 61 trials (21 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 61 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 61 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 61 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 61 trials (17 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 61 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 58 trials (22 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 58 trials (30 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 57 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 57 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 57 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 57 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 56 trials (19 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 56 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 56 trials (28 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 56 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Asparaginaseother 51 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 50 trials (20 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 50 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 49 trials (27 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 49 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gilteritinibsmall molecule 48 trials (24 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 47 trials (10 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 47 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 46 trials (13 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cladribinesmall molecule 45 trials (14 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 45 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 42 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 42 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 42 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 40 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 39 trials (28 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 38 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 38 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 37 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thioguaninesmall molecule 37 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 36 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 36 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 34 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 33 trials (13 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 33 trials (15 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegaspargaseother 32 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 31 trials (15 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 30 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Quizartinibsmall molecule 30 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 29 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Midostaurinsmall molecule 28 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nilotinibsmall molecule 28 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 27 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ivosidenibsmall molecule 26 trials (21 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 26 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 25 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enasidenibsmall molecule 24 trials (13 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 24 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 24 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanubrutinibsmall molecule 24 trials (17 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 23 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 23 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall molecule 22 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ofatumumabmonoclonal antibody 21 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 21 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 20 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Revumenibsmall molecule 19 trials (16 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epcoritamabmonoclonal antibody 18 trials (15 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 18 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 18 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal antibody 17 trials (12 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxyureasmall molecule 17 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 17 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisolonesmall molecule 17 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tagraxofuspother 17 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Omacetaxine Mepesuccinatesmall molecule 16 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 16 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Treosulfansmall molecule 16 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mosunetuzumabmonoclonal antibody 15 trials (13 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Polatuzumab Vedotinadc 15 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 15 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 14 trials (10 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 14 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 14 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 13 trials (10 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nelarabinesmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nimotuzumabmonoclonal antibody 13 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 13 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ripretinibsmall molecule 13 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 13 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 12 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 12 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pirtobrutinibsmall molecule 12 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ziftomenibsmall molecule 12 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 11 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glofitamabmonoclonal antibody 11 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idelalisibsmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegargiminaseother 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Volasertibsmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Guadecitabinesmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pacritinibsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 10 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avapritinibsmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bosutinibsmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 9 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glasdegibsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nedaplatinsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axicabtagene Ciloleucelgene therapy 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX Regimen 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Icotinibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Loncastuximab Tesirineadc 8 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vindesinesmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enfortumab Vedotinadc 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX-4 Regimen 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olutasidenibsmall molecule 7 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tafasitamabmonoclonal antibody 7 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisagenlecleucelcell therapy 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amsacrinesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chlorambucilsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crenolanibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Donor Lymphocyte Infusion 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immune Checkpoint Inhibitor 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leuprolideother 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lisocabtagene Maraleucelgene therapy 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Odronextamabmonoclonal antibody 6 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azathioprinesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Barasertibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hematopoietic Cell Transplantation 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mocetinostatsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Navtemadlinsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Onartuzumabmonoclonal antibody 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Morphology | 5 | Observed | clinicaltrials | graph → |